Earnings History Data for Blue Water Acquisition (CRXT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Blue Water Acquisition
Clarus Therapeutics Inc. is a specialty pharmaceutical company which provide solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women. The Company's commercial product includes JATENZO(R). Clarus Therapeutics Inc., formerly known as Blue Water Acquisition Corp., is based in NORTHBROOK, Ill.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18-08-2022 | AH | 4:05 PM ET (Aug 18) |
CRXT | Blue Water Acquisition | 15.00 | -0.24 | -0.32 | 0.00 | Clarus Therapeutics GAAP EPS of -$0.24 beats by $0.06, revenue of $4.05M misses by $0.92M [8/18/2022 4:26 PM] |
0.2051 | -0.08 (-27.58%) |
0.24 | -0.05 (-15.96%) |
0.20 - 31.24 | 7,031,721 | 1,560,000 | 467,523 | |
| 16-05-2022 | AH | 4:05 PM ET (May 16) |
CRXT | Clarus Therapeutics Holdings, Inc. | 22.48 | -0.61 | -0.59 | 0.00 | Clarus Therapeutics GAAP EPS of -$0.61 misses by $0.15, revenue of $4.01M misses by $0.94M [5/16/2022 4:11 PM] |
0.4441 | -0.09 (-17.36%) |
0.45 | -0.09 (-16.26%) |
0.42 - 31.24 | 6,459,102 | 11,980,000 | 521,009 | |
| 30-03-2022 | AH | 4:05 PM ET (Mar 30) |
CRXT | Blue Water Acquisition | 41.00 | -0.41 | -0.47 | 0.00 | Clarus Therapeutics reports Q4 results [3/30/2022 5:40 PM] |
1.47 | -0.61 (-29.32%) |
1.65 | -0.43 (-20.67%) |
0.61 - 31.24 | 1,498,133 | 6,290,000 | 94,537 | |